Orthovita Issued Patent for Development, Use of Composite Implants

Orthovita, a developer of synthetic biomaterials for the orthopedic market, announced that it has been granted a U.S. patent covering the development and use of composite shaped bodies for a range of applications in orthopedic surgery. The patent covers nine new claims for composite implants, including the use of Orthovita's VITOSS Bone Graft Substitute in combination with a medicament such as a protein or antibiotic.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050315005177&newsLang=en)